1Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med, 1987, 107:216.
2Salvaterra CG, Rubin l.J. Investigation and management of pulmonary hypertension in chronic obstructive pulmonary disease. Am Rev Respir Dis, 1993,148:1414.
3Vallerie V McLaughlin, Michael D, et al. Pulmonary arterial hypertension. Circulation, 2006, 114 : 1417.
5Badesch DB, Abman SH, Ahearn GS, et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-hased clinical practice guidelindes. Chest, 2004, 126: 35S.
6Siobal MS. Pulmonary vasodilators. Respir Care, 2007,52: 885.
7Reeves JT. High adventure in pulmonary hypertension: acute and chronic hypoxia are not the same. Am J Respir Cric Care Mod, 2002.166 : 1537.
8Zwissler B. Der "kranke" rechte Ventrikel. Intensivmed, 2001, 38 : 264.
9Parole SK, Finer NN. Experimental and clinical effects of magnesium infusion in the treatment of neonatal pulmonary hypertension. Magnes Res, 1995.8 : 373.
10Nootens M, Schrader B, Kaufmann E, et al. Comparative acute et-fects of adenosine and prostacyclin in primary pulmonary hy pertension. Chest, 1995,107 : 54.
33rd World PAH Symposium. Pulmonary arterial hypertension: epidemiology, pathobiology, assessment and therapy [ J ]. J Am Coll Cardiol,2004,43 (12 Suppl S):1S-90S.
4Rubin LJ. American College of Chest Physicians. Diagnosis and management of pulmonary arterial hypertension: ACCP evidencebased clinical practice guidelines [ J ]. Chest,2004,126 : 1 - 92.
5Galie N,Torbicki A, Barst R, et al. ESC guidelines:guidelines on the diagnosis and treatment of pulmonary arterial hypertension [ J ].Eur Heart J,2004,25:2243 -2278.
6Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension [ J ]. J Am Coll Cardiol,43 (12) :5 -12.
7Mcgoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension [ J ]. Chest,2004,126:14 -34.
8McQuillan BM, Picard MH, Leavitt M, et al. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects [ J ]. Circulation, 2001,104 :2797 - 2802.
9Hoeper MM, Oudiz RJ, Peacock A, et al. End points and clinical trial designs in pulmonary arterial hypertension [ J ]. J Am Coll Cardiol,2004,43:48 - 55.
10Gali~ N,Hoeper MM,Humbert M ,et a/.Guidelines for the diagnosis and treatment of pulmonary hypertension:the task force for the diagnosis and treatment of pulmonaryhypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS),endorsed by the International Society of Heart and Lung Transplanta- tion (ISHLT)[J].Eur Heart J, 2009,30 (20) : 2493-2537.
